Incidence and management of toxicity associated with ibrutinib and idelalisib: a practical approach

Iris de Weerdt, Suzanne M. Koopmans, Arnon P. Kater*, Michel van Gelder

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Pages (from-to)1629-1639
Number of pages11
JournalHaematologica-the Hematology Journal
Volume102
Issue number10
DOIs
Publication statusPublished - Oct 2017

Keywords

  • CHRONIC LYMPHOCYTIC-LEUKEMIA
  • B-CELL-RECEPTOR
  • SINGLE-AGENT IBRUTINIB
  • RANDOMIZED CONTROLLED-TRIALS
  • NON-HODGKIN-LYMPHOMA
  • ATRIAL-FIBRILLATION
  • OPEN-LABEL
  • AUTOIMMUNE CYTOPENIAS
  • INHIBITOR IBRUTINIB
  • 3-KINASE P110-DELTA

Cite this